Preferred Name

Entacapone

Synonyms
Definitions

A nitrocatechol compound with anti-parkinsonian property. Entacapone is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), which catalyzes the transfer of the methyl group of S-adenosyl-L-methionine to the phenolic group of substrates that contain a catechol structure including dihydroxyphenylalanine (DOPA), catecholamines (dopamine, norepinephrine, and epinephrine) and their hydroxylated metabolites. When administered in conjunction with dopaminergic agents such as L-DOPA, entacapone prevents the metabolism and inactivation of adjunct drugs, thereby increasing the bioavailability of these compounds by facilitating their passage across the blood-brain barrier.

ID

http://purl.obolibrary.org/obo/NCIT_C61746

CAS_Registry

130929-57-6

CHEBI_ID

CHEBI:4798

Chemical_Formula

C14H15N3O5

code

C61746

Contributing_Source

FDA

definition

A nitrocatechol compound with anti-parkinsonian property. Entacapone is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), which catalyzes the transfer of the methyl group of S-adenosyl-L-methionine to the phenolic group of substrates that contain a catechol structure including dihydroxyphenylalanine (DOPA), catecholamines (dopamine, norepinephrine, and epinephrine) and their hydroxylated metabolites. When administered in conjunction with dopaminergic agents such as L-DOPA, entacapone prevents the metabolism and inactivation of adjunct drugs, thereby increasing the bioavailability of these compounds by facilitating their passage across the blood-brain barrier.

FDA_UNII_Code

4975G9NM6T

in_subset

http://purl.obolibrary.org/obo/NCIT_C63923

http://purl.obolibrary.org/obo/NCIT_C176424

label

Entacapone

Legacy Concept Name

Entacapone

NCI_Drug_Dictionary_ID

801668

PDQ_Closed_Trial_Search_ID

801668

PDQ_Open_Trial_Search_ID

801668

Preferred_Name

Entacapone

prefixIRI

NCIT:C61746

prefLabel

Entacapone

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C0876730

subClassOf

http://purl.obolibrary.org/obo/NCIT_C38149

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_4798 CHEBI LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/387018000 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/RCD/dqD.. RCD LOOM
http://www.co-ode.org/ontologies/galen#Entacapone GALEN LOOM
http://purl.bioontology.org/ontology/MESH/C071192 MESH LOOM
http://www.phoc.org.cn/pmo/class/PMO_00026543 PMAPP-PMO LOOM
http://purl.bioontology.org/ontology/RXNORM/60307 RXNORM LOOM
http://purl.bioontology.org/ontology/NDDF/007684 NDDF LOOM
http://stirdf.jst.go.jp/id/200907027701540528 IOBC LOOM
http://www.semanticweb.org/ontologies/2011/1/Ontology1296772722296.owl#EPO_00000069 PDON LOOM
http://purl.obolibrary.org/obo/CHEBI_4798 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_4798 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_4798 COVID-19 LOOM
http://purl.obolibrary.org/obo/CHEBI_4798 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_4798 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_4798 NIFSTD LOOM
http://www.drugbank.ca/drugs/DB00494 FTC LOOM
http://purl.bioontology.org/ontology/VANDF/4021181 VANDF LOOM
http://purl.jp/bio/4/id/200906023509610777 IOBC LOOM
https://go.drugbank.com/drugs/DB00494 MDM LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61746 NCIT LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#18076 OCHV LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0165921 OCHV LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C071192 RH-MESH LOOM
http://purl.bioontology.org/ontology/ATC/N04BX02 ATC LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148629 NDFRT LOOM